Anticoagulation Flashcards
CHADS2-VASC calculation
C - congestive heart failure/ left ventricle dysfunction
H - hypertension
A - age >75
D - diabetes
S - stroke, TIA x 2
V - vascular disease (MI, PAD, aortic plaque)
A - age >65 - 74
S - sex (female gets a point)
HAS Bled Score
H - hypertension >160mmHg
A - abnormal renal/liver (1 pt each) (scr >2.2)
S - stroke
B - bleeding hx (anemia, bleeding disorder, prior bleed)
L - labile INR (time in range <60%)
E - elderly >65 years old
D - drug or alcohol excess (1 pt each)
What disease state do we use CHADS2-VASC and HAS-BLED?
Non valvular A fib
CHADS2 Score and treatment options
Men 0 / Female 1 - ASA or nothing
Men 1 / Female 2 - ASA or DOAC or nothing
Men >2 / Female 3 - DOAC
HAS BLED Score to worry about bleeding with Afib DOAC treatment
> =3
try to reduce risk factors if you can
Warfarin goal time in range
> 65%
duration of needed anticoagulation before cardioversion of Afib
3 weeks
duration to anticoagulated after cardio version of afib
4 weeks
more potent isomer of warfarin
S is 5 x more potent
indication to start lower dosing of warfarin initially
> age
low body weight
liver / heart / thyroid disorder
low albumin
warfarin drug interactions
decreased absorption - cholestyramine and sucralfate
CYP2C9 hits S enantiomor harder than 3A4
fevers eat up clotting factors faster
OTC - garlic and ASA
reduce INR - phenytoin, phenobarbital, carbamazepine, rifampin, St John’s wort
reduced clearance - flagyl, bactrim, fluconazole, isoniazid, fluoxetine, sertraline, amiodarone
Dabigatran Dosing
Afib - 150mg BID
Total Hip - dabigatran 110mg BID, then 220 daily
VTE - 5 days injection then 150mg BID
Rivaroxaban Dosing
Afib - 20mg PM
Total Hip/Knee - 10mg daily (don’t need food)
VTE: 15mg BID x 21 days, then 20mg PM, cut to 10mg after 6 mo.
Dabigatran renal dosing cutoff
Afib: CrCl <30 use 75mg BID, CrCl <15 do not use
VTE: CrCl <30 do not use
Rivaroxaban renal dosing cutoff
Afib - CrCl <50 - 15mg PM
VTE: avoid if CrCl <15
Apixaban Dosing
Afib - 5mg BID
Total Hip/Knee - apixaban 2.5mg BID (Hip x 35, Knee x 12)
VTE: 10mg BID x 7 days, then 5mg BID, 2.5mg after 6 mo.
Apixaban renal dosing cutoff
Afib - 2.5mg BID if >80yo, <60kg, sCr >1.5
VTE: avoid if CrCl <15, sCr >2.5
Edoxaban Dosing
Afib - 60mg daily
VTE - 5 days injectable then 60mg daily
Edoxaban renal dosing cutoff
Afib - <50 - 30mg daily, avoid if CrCl >95
dialysis effects on DOACs
Do Not Use - edoxaban, dabigatran
Reduce Dose - apixaban, rivaroxaban
INR to start DOAC
rivaroxaban <3
edoxaban <2.5
apixaban and dabigatran <2
Afib + PCI anticoagulants of choice
DOAC and clopidogrel x 1 yr, then DOAC only
if high bleed risk may do 6 months or 3 months of plavix
bioprosthetic valve replacement - anticoagulant choice and duration
ASA - could do warfarin for 3 - 6 months - but should do ASA for life
transcatheter aortic valve replacement (TAVR) Less invasive
ASA only but could do aspirin/plavix x 6 mo. or warfarin x 3 mo.
bioprosthetic valve replacement in Afib
guidelines say to use warfarin within the first 3 months of replacement, but clinically we use DOACs
mechanical heart valve replacement
warfarin only
increase target INR to 2.5 - 3.5 if in the mitral position
can add ASA low dose if indication for anti-platelet therapy